Walleye Capital’s Labcorp LH Stock Holding History

Walleye Capital’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-900	Closed	-$226K	–	4702
2025 Q4	$226K	Sell	900 -700	-44%	-$186K	﹤0.01%	3477
2025 Q3	$459K	Sell	1,600 -600	-27%	-$161K	﹤0.01%	2683
2025 Q2	$578K	Sell	2,200 -1,500	-41%	-$365K	﹤0.01%	2512
2025 Q1	$861K	Sell	3,700 -7,700	-68%	-$1.87M	﹤0.01%	2097
2024 Q4	$2.61M	Buy	11,400 +4,000	+54%	+$918K	0.01%	1536
2024 Q3	$1.65M	Sell	7,400 -600	-8%	-$132K	﹤0.01%	2149
2024 Q2	$1.63M	Sell	8,000 -100	-1%	-$20.3K	﹤0.01%	2313
2024 Q1	$1.77M	Buy	8,100 +4,200	+108%	+$925K	﹤0.01%	2081
2023 Q4	$886K	Buy	3,900 +300	+8%	+$63K	﹤0.01%	2456
2023 Q3	$724K	Buy	3,600 +3,134	+673%	+$661K	﹤0.01%	2516
2023 Q2	$96.5K	Buy	+466	New	+$90.4K	﹤0.01%	3448
2019 Q4	–	Sell	-10,360	Closed	-$1.5M	–	2050
2019 Q3	$1.5M	Buy	+10,360	New	+$1.51M	0.09%	308

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Walleye Capital's LH Position: Q4 2025 in Review

Walleye Capital sold out of Labcorp (LH) in Q4 2025, closing a stake of 367 shares — an estimated $97.5K sold.

Walleye Capital first reported a position in LH in Q3 2019 and held it in 11 quarters. The position peaked at $13.1M in Q3 2024. 1,024 funds tracked by Wall St. Rank hold LH as of Q4 2025.

Walleye Capital reported no remaining Labcorp position as of Q4 2025 after selling out during the quarter.
Walleye Capital sold 367 Labcorp shares in Q4 2025, an estimated $97.5K.
Walleye Capital first reported a position in Labcorp in Q3 2019 and held it in 11 quarters.
Walleye Capital's Labcorp position peaked at $13.1M in Q3 2024.
1,024 funds tracked by Wall St. Rank held Labcorp as of Q4 2025.

Based on Walleye Capital's 13F filing for Q4 2025, filed 13 Feb 2026.